Jianping Jia

2005–2025 年に発表

135
論文数
17,929
被引用数
55
h 指数
119
i10 指数

被引用数

Jianping Jia の年別被引用数2000 年: 被引用 1 件2004 年: 被引用 1 件2005 年: 被引用 2 件2007 年: 被引用 4 件2008 年: 被引用 5 件2009 年: 被引用 7 件2010 年: 被引用 7 件2011 年: 被引用 17 件2012 年: 被引用 41 件2013 年: 被引用 62 件2014 年: 被引用 86 件2015 年: 被引用 97 件2016 年: 被引用 90 件2017 年: 被引用 100 件2018 年: 被引用 135 件2019 年: 被引用 447 件2020 年: 被引用 615 件2021 年: 被引用 803 件2022 年: 被引用 951 件2023 年: 被引用 796 件2024 年: 被引用 1,457 件2025 年: 被引用 699 件2026 年: 被引用 30 件2001〜2003 年は被引用が無いため表示していません2006 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図中国: 引用元論文 3,194 件、この内訳の 35.1%アメリカ合衆国: 引用元論文 1,551 件、この内訳の 17%イギリス: 引用元論文 509 件、この内訳の 5.6%カナダ: 引用元論文 256 件、この内訳の 2.8%オーストラリア: 引用元論文 252 件、この内訳の 2.8%イタリア: 引用元論文 240 件、この内訳の 2.6%ドイツ: 引用元論文 234 件、この内訳の 2.6%インド: 引用元論文 183 件、この内訳の 2%スウェーデン: 引用元論文 181 件、この内訳の 2%スペイン: 引用元論文 174 件、この内訳の 1.9%フランス: 引用元論文 169 件、この内訳の 1.8%韓国: 引用元論文 161 件、この内訳の 1.8%
0%35.1%その他 22%

分野

  • Medicine58.3%
  • Neuroscience17.3%
  • Biochemistry, Genetics and Molecular Biology14.2%
  • Psychology1.9%
  • Health Professions1.4%
  • Computer Science1%
  • その他5.9%

トピック

  • Alzheimer's disease research and treatments7.7%
  • Dementia and Cognitive Impairment Research7.6%
  • Acute Ischemic Stroke Management3.3%
  • Functional Brain Connectivity Studies3.3%
  • Neuroinflammation and Neurodegeneration Mechanisms3.2%
  • Neurological Disease Mechanisms and Treatments2.6%
  • その他72.3%

共著者

全論文

検索で開く
  1. Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yan Lv, Li Yang, Minchen Kan, Huiying Zhao, S.H. Wang, Shanshan Yang, Hao Li, Zhongling Liu, Qi Wang, Wei Qin, Jianping Jia, Meina Quan, Yan Wang, Wenwen Li, Shuman Cao, Lingzhi Xu, Yue Han, Junhua Liang, Yuchen Qiao, Qi Qin, Qiongqiong Qiu - The Lancet Public Health 2020 被引用: 1,704

  2. Stroke in China: advances and challenges in epidemiology, prevention, and management

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Chuanqiang Pu, Jianping Jia, Tong Zhang, Xinfeng Liu, Suming Zhang, Peng Xie, Dongsheng Fan, Xunming Ji, Ka Sing Wong, Longde Wang, Chenchen Wei, Yanan Wang, Yajun Cheng, Yunhai Liu, Xin Li, Qiang Dong, Jinsheng Zeng, Bin Peng, Yun Xu, Yi Yang, Yilong Wang, Gang Zhao, Wei Wang, Yuming Xu, Qingwu Yang, Zhiyi He, Shaoshi Wang, Chao You, Ying Gao, Dong Zhou, Li He, Zixiao Li, Jie Yang, Chunyan Lei, Yuhua Zhao, Junfeng Liu, Shuting Zhang, Wendan Tao, Zilong Hao, Deren Wang, Shihong Zhang - The Lancet Neurology 2019 被引用: 1,613

  3. Biomarker Changes during 20 Years Preceding Alzheimer’s Disease

    著者: , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2024 被引用: 396

  4. Dementia in China: epidemiology, clinical management, and research advances

    著者: , , , , , , , , , , , , , , , , , , , - The Lancet Neurology 2019 被引用: 861

  5. The cost of Alzheimer's disease in China and re‐estimation of costs worldwide

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Enyan Yu, Benyan Luo, Yan‐Jiang Wang, Shanshan Yang, Qiumin Qu, Qihao Guo, Furu Liang, Jintao Zhang, Lan Tan, Lu Shen, Kunnan Zhang, Jinbiao Zhang, Dantao Peng, Muni Tang, Peiyuan Lv, Boyan Fang, Lan Chu, Longfei Jia, Serge Gauthier - Alzheimer s & Dementia 2018 被引用: 754

  6. Concordance between the assessment of Aβ42, T‐tau, and P‐T181‐tau in peripheral blood neuronal‐derived exosomes and cerebrospinal fluid

    著者: , , , , , , , , , , , , , , , , , - Alzheimer s & Dementia 2019 被引用: 377

  7. Clopidogrel with Aspirin in Acute Minor Stroke or Transient Ischemic Attack

    著者: , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2013 被引用: 1,838

  8. Blood neuro‐exosomal synaptic proteins predict Alzheimer's disease at the asymptomatic stage

    著者: , , , , , , , , , , , , , , , - Alzheimer s & Dementia 2020 被引用: 256

  9. Association between healthy lifestyle and memory decline in older adults: 10 year, population based, prospective cohort study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - BMJ 2023 被引用: 241

  10. Evidence-based prevention of Alzheimer's disease: systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Neurology Neurosurgery & Psychiatry 2020 被引用: 487

  11. Chinese Mini Mental Status in Elderly Chinese: A Population-Based Normative Study

    著者: , , - Journal of Alzheimer s Disease 2016 被引用: 564

  12. Montreal Cognitive Assessment in Detecting Cognitive Impairment in Chinese Elderly Individuals: A Population-Based Study

    著者: , , , , , , , , - Journal of Geriatric Psychiatry and Neurology 2011 被引用: 562

  13. Gut inflammation triggers C/EBPβ/δ‐secretase‐dependent gut‐to‐brain propagation of Aβ and Tau fibrils in Alzheimer’s disease

    著者: , , , , , , , , - The EMBO Journal 2021 被引用: 133

  14. Single-Cell RNA Sequencing of Peripheral Blood Reveals Immune Cell Signatures in Alzheimer’s Disease

    著者: , - Frontiers in Immunology 2021 被引用: 153

  15. Gut Microbiota Changes and Their Correlation with Cognitive and Neuropsychiatric Symptoms in Alzheimer’s Disease

    著者: , , , , - Journal of Alzheimer s Disease 2021 被引用: 128

  16. Delta-secretase cleaves amyloid precursor protein and regulates the pathogenesis in Alzheimer’s disease

    著者: , , , , , , , , , , , , - Nature Communications 2015 被引用: 279

  17. Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer’s Disease: Cohort Analysis as Modified Primary Outcome in a Phase III Clinical Trial

    著者: , , , , , , , , , , , , , , , , , , , , , - Journal of Alzheimer s Disease 2017 被引用: 217

  18. B vitamins and prevention of cognitive decline and incident dementia: a systematic review and meta-analysis

    著者: , , , , - Nutrition Reviews 2021 被引用: 140

  19. Post-COVID cognitive dysfunction: current status and research recommendations for high risk population

    著者: , , , , , - The Lancet Regional Health - Western Pacific 2023 被引用: 106

  20. Magnolol improves Alzheimer's disease-like pathologies and cognitive decline by promoting autophagy through activation of the AMPK/mTOR/ULK1 pathway

    著者: , - Biomedicine & Pharmacotherapy 2023 被引用: 100

  21. The prevalence of dementia in urban and rural areas of China

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Alzheimer s & Dementia 2013 被引用: 454

  22. Genetic Phenotypes of Alzheimer’s Disease: Mechanisms and Potential Therapy

    著者: , , , , - Phenomics 2023 被引用: 52

  23. Disrupted Functional Brain Connectome in Individuals at Risk for Alzheimer's Disease

    著者: , , , , , , , , - Biological Psychiatry 2012 被引用: 433

  24. C/EBPβ regulates delta-secretase expression and mediates pathogenesis in mouse models of Alzheimer’s disease

    著者: , , , , , , , , , , , , - Nature Communications 2018 被引用: 136